Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: Signaling through CD14 and mitogen-activated protein kinase

Pediatric Research

Volumn 54, Issue 3, 2003, Pages 297-305

  Reddi, Krisanavane ^a   Phagoo, Stephen B ^a   Anderson, Kathryn D ^a   Warburton, David ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD14 ANTIGEN; CYCLOHEXIMIDE; DACTINOMYCIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEINASE K;

ARTICLE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIGENS, CD14; BURKHOLDERIA CEPACIA; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN SYNTHESIS INHIBITORS; PULMONARY ALVEOLI; SIGNAL TRANSDUCTION;

EID: 0042035642     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000076661.85928.1D     Document Type: Article

References (31)

1. Bye MR, Ewig JM, Quitell LM 1994 Cystic fibrosis. Lung 172:251-270
2. Auerbach HS, Williams M, Kirkpatrick J, Cohen HR 1985 Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 2:686-688
3. Govan JRW, Hughes JE, Vandamme P 1996 Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45:395-407
4. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H 1984 Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104:206-210
5. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M 1995 Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152:2111-2118
6. Norman D, Elborn JS, Cordon SM, Rayner RJ, Wiseman MS, Hiller EJ, Shale DJ 1991 Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 46:91-95
7. Dean TP, Dai Y, Shute JK, Church MK, Warner JO 1993 Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 34:159-161
8. Keane MP, Strieter RM 2000 Chemokine signaling in inflammation. Crit Care Med 28:N13-N26
9. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, Billstrom MA, Henson PM, Johnson GL, Wrthen G 1999 Selective activation and functional significance of p38 alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103:851-858
10. Burns JL, Jonas Mechthild J, Chi EY, Clark DK, Berger A, Griffith A 1996 Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 64:4054-4059
11. Martin DW, Mohr CD 2000 Invasion and intracellular survival of Burkholderia cepacia Infect Immun 68:24-29
12. Keig PM, Ingham E, Kerr KG 2001 Invasion of human type II pneumocytes by Burkholderia cepacia. Microb Pathog 30:167-170
13. Mori N, Oishi K, Sar B, Mukaida N, Nagatake T, Matsushima K, Yamamoto N 1999 Essential role of transcription factor nuclear factor-κB in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cells. Infect Immun 67:3872-3878
14. Palfreyman RW, Watson ML, Eden C, Smith AW 1997 Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun 65:617-622
15. Leidal KG, Munson KL, Denning GM 2001 Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and Rantes expression by human airway epithelial cells. Am J Respir Cell Mol Biol 25:186-195
16. Burns JL, Wadsworth CH, Barry J, Goodall CP 1996 Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 40:307-313
17. Steffen MJ, Ebersole JL 1996 Sequential ELISA for cytokine levels in limited volumes of biological fluids. Biotechniques 21:504-509
18. Weinberg A, Holt SC 1990 Interaction of Treponema denticola TD-4, GM-1, and MS25 with human gingival fibroblasts. Infect Immun 58:1720-1729
19. Jung CJ, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewsa E, Kagnoff MF 1995 A distinct array of pro-inflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55-65
20. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M 1995 Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:283-286
21. De Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA 1997 Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol 273:G1290-G1296
22. Lewin C, Doherty C, Govan JRW 1993 In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloroamphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother 37:123-125
23. Simpson IN, Finlay J, Winstanley DJ, Dewhurst N, Nelson J, Butler S, Govan JRW 1994 Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother 34:353-361
24. Zughaier SM, Ryley HC, Jackson SK 1999 Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 67:1505-1507
25. Shimomura H, Matsuuraa M, Saito S, Hirai Y, Isshiki Y, Kawahara K 2001 Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1β-inducing ability. Infect Immun 69:3663-3669
26. Reddi K, Nair SP, White PA, Hodges S, Tabona P, Meghji S, Poole S, Wilson M, Henderson B 1996 Surface-associated material from the bacterium Actinobacillus actinomycetemcomitans contains a peptide which, in contrast to lipopolysaccharide, directly stimulates fibroblast interleukin-6 gene transcription. Eur J Biochem 236: 871-876
27. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE 1998 Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 66:5777-5784
28. Ratner AJ, Bryan R, Weber A, Nguyen S, Barnes D, Pitt A, Gelber S, Cheung A, Prince A 2001 Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem 276:19267-19275
29. Abraham E 2000 NF-κB activation. Crit Care Med 28:N100-N104
30. Sajjan U, Thanassoulis G, Cherapanov V, Lu A, Sjolin C, Steer B, Wu YJ, Rotstein OD, Kent G, Mckerlie C, Forstner J, Downey GP 2001 Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr-/- mice. Infect Immun 69:5138-5150
31. Kazachkov M, Lager J, Lipuma J, Barker PM 2001 Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr Pulmonol 32:338-340